Kuchyne na miru

Noteworthy

Jul 11, 2019
Pharmaceutical Executive
New guidances open the door to interchangeables and less costly insulin.
Jul 08, 2019
While culture may "eat" strategy, shared understanding creates both culture and strategy, write Steve Figman and Sean Robertson.
Jul 07, 2019
By
Justin Grossman outlines three practices that are key to navigating today’s multiplayer agency landscape — and getting more value from each external vendor.
Jul 02, 2019
Pharmaceutical Executive
The opioid crisis dominated the news in this year’s annual audit of press coverage of the pharmaceutical industry. Stephen J. Porth and George P. Sillup report.
Jul 01, 2019
While there are challenges at every turn, the promise of outcomes-based contracting is a level of care for patients that might otherwise not be possible, while striking the right balance of benefits and risks for all parties involved, writes Melonie Warfel.
Jul 01, 2019
R&D organizations can leverage FDA’s final guidance on pre-approval information exchange, otherwise known as PIE, to engage with payers prior to regulatory approval and commercial launch.
Jun 28, 2019
Pharmaceutical Executive
Its use, new data shows, could boost the economic benefit profile of more “common” drugs—and better inform HTA and payer decision-making. Barbara Arone reports.
Jun 26, 2019
By
Both foreign and domestic pharmas are in a race to bring PD-1/PD-L1 inhibitors into China, writes Jin Zhang.
Jun 24, 2019
Pharmaceutical Executive
Robert Groebel offers six ways pharma MA departments can drive more collaborative relationships with caregivers.
Jun 21, 2019
Pharmaceutical Executive
Exploring the critical go-to strategies for biopharma C-suite executives in navigating organizational disruption and the impact of global change and volatility on their employees and business.
native1_300x100
topobzor.info

website development

гранитная плитка цена
lorem ipsum